Literature DB >> 26111534

Loss-of-Function SCN5A Mutations Associated With Sinus Node Dysfunction, Atrial Arrhythmias, and Poor Pacemaker Capture.

David Y Chiang1, Jeffrey J Kim1, Santiago O Valdes1, Caridad de la Uz1, Yuxin Fan1, Jeffrey Orcutt1, Melissa Domino1, Melissa Smith1, Xander H T Wehrens1, Christina Y Miyake2.   

Abstract

BACKGROUND: Cardiac device implantation can be complicated by inability to adequately place leads because of significant lead capture issues. This study sought to determine whether there are genetic bases that underlie poor lead capture. METHODS AND
RESULTS: Retrospective review of all patients with structurally normal hearts who underwent new device implantation at Texas Children's Hospital between 2009 and 2014 was performed. Patients with inability to capture at 10 V or a final capture threshold ≥3 V at 0.4 ms during implant were analyzed. Among a total of 136 patients (median age, 13 years; range, 3 days to 46 years), 11 patients (8.1%) who underwent dual chamber device implantation had elevated thresholds in the atria (4), ventricle (3), or both chambers (4; atrial-lead threshold, 4.7±4.3 versus 0.7±0.3 V; ventricular-lead, 3.0±3.3 versus 0.7±0.3 V). All 11 patients presented with sinus node dysfunction and 10 had atrial arrhythmias. At implant, inability to find atrial capture was seen in 4 patients. Three demonstrated intermittent complete loss of ventricular capture after implantation: 1 has recurrent syncope, 2 eventually died. Genetic testing performed in 10 demonstrated 7 patients with 6 distinct SCN5A mutations, all predicted to be severe loss-of-function mutations by bioinformatic analyses. In the remaining patients, although putative pathogenic mutations were not found, multiple SCN5A polymorphisms were identified in 2 and a desmin mutation in 1.
CONCLUSIONS: This study suggests that significant capture issues at implant may be because of loss-of-function SCN5A mutations, providing new insights into SCN5A function. Recognition of this association may be critical for planning device implantation strategies and patient follow-up.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Brugada syndrome; NaV1.5 voltage-gated sodium channel; SCN5A protein, human; atrial tachyarrhythmia with short PR; cardiac pacemaker, artificial; implantable cardioverter-defibrillators; sick sinus syndrome

Mesh:

Substances:

Year:  2015        PMID: 26111534      PMCID: PMC5119522          DOI: 10.1161/CIRCEP.115.003098

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  14 in total

1.  Homozygous mutation in SCN5A associated with atrial quiescence, recalcitrant arrhythmias, and poor capture thresholds.

Authors:  Keila N Lopez; Jamie A Decker; Richard A Friedman; Jeffrey J Kim
Journal:  Heart Rhythm       Date:  2010-10-13       Impact factor: 6.343

2.  Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro.

Authors:  Hiroshi Watanabe; Tao Yang; Dina Myers Stroud; John S Lowe; Louise Harris; Thomas C Atack; Dao W Wang; Susan B Hipkens; Brenda Leake; Lynn Hall; Sabina Kupershmidt; Nagesh Chopra; Mark A Magnuson; Naohito Tanabe; Björn C Knollmann; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2011-08-08       Impact factor: 29.690

3.  Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Authors:  I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

4.  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.

Authors:  Timothy M Olson; Virginia V Michels; Jeffrey D Ballew; Sandra P Reyna; Margaret L Karst; Kathleen J Herron; Steven C Horton; Richard J Rodeheffer; Jeffrey L Anderson
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

5.  Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.

Authors:  M B Rook; C Bezzina Alshinawi; W A Groenewegen; I C van Gelder; A C van Ginneken; H J Jongsma; M M Mannens; A A Wilde
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

6.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

7.  A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.

Authors:  Carmen R Valdivia; David J Tester; Benjamin A Rok; Co-Burn J Porter; Thomas M Munger; Arshad Jahangir; Jonathan C Makielski; Michael J Ackerman
Journal:  Cardiovasc Res       Date:  2004-04-01       Impact factor: 10.787

8.  A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill.

Authors:  W Antoinette Groenewegen; Mehran Firouzi; Connie R Bezzina; Saskia Vliex; Irene M van Langen; Lodewijk Sandkuijl; Jeroen P P Smits; Miriam Hulsbeek; Martin B Rook; Habo J Jongsma; Arthur A M Wilde
Journal:  Circ Res       Date:  2003-01-10       Impact factor: 17.367

9.  Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.

Authors:  Paola G Meregalli; Hanno L Tan; Vincent Probst; Tamara T Koopmann; Michael W Tanck; Zahurul A Bhuiyan; Frederic Sacher; Florence Kyndt; Jean-Jacques Schott; J Albuisson; Philippe Mabo; Connie R Bezzina; Herve Le Marec; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2008-11-11       Impact factor: 6.343

10.  Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A).

Authors:  D Woodrow Benson; Dao W Wang; Macaira Dyment; Timothy K Knilans; Frank A Fish; Margaret J Strieper; Thomas H Rhodes; Alfred L George
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more
  6 in total

1.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Back Sternick Eduardo; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong-Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti Mac Intyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Pablo Ochoa Juan; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  J Arrhythm       Date:  2022-05-31

2.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Eduardo Back Sternick; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti MacIntyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Juan Pablo Ochoa; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  Europace       Date:  2022-09-01       Impact factor: 5.486

3.  Novel SCN5A variants identified in a group of Iranian Brugada syndrome patients.

Authors:  Taraneh Ghaffari; Naser Mirhosseini Motlagh; Abdolreza Daraei; Majid Tafrihi; Mehrdad Saravi; Davood Sabour
Journal:  Funct Integr Genomics       Date:  2021-02-27       Impact factor: 3.410

Review 4.  Inherited bradyarrhythmia: A diverse genetic background.

Authors:  Taisuke Ishikawa; Yukiomi Tsuji; Naomasa Makita
Journal:  J Arrhythm       Date:  2015-11-19

Review 5.  Brugada syndrome in children - Stepping into unchartered territory.

Authors:  Shashank P Behere; Steven N Weindling
Journal:  Ann Pediatr Cardiol       Date:  2017 Sep-Dec

6.  Mutations in NaV1.5 Reveal Calcium-Calmodulin Regulation of Sodium Channel.

Authors:  Eyal Nof; Leonid Vysochek; Eshcar Meisel; Elena Burashnikov; Charles Antzelevitch; Jerome Clatot; Roy Beinart; David Luria; Michael Glikson; Shimrit Oz
Journal:  Front Physiol       Date:  2019-06-05       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.